HCYT
Price:
$0.995
Market Cap:
$624.98K
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.[Read more]
Industry
Biotechnology
IPO Date
2014-12-19
Stock Exchange
PNK
Ticker
HCYT
According to H-CYTE, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.06. This represents a change of -61.15% compared to the average of -0.17 of the last 4 quarters.
The mean historical PE Ratio of H-CYTE, Inc. over the last ten years is -10.45. The current -0.06 PE Ratio has changed -38.64% with respect to the historical average. Over the past ten years (40 quarters), HCYT's PE Ratio was at its highest in in the September 2020 quarter at 0.26. The PE Ratio was at its lowest in in the December 2014 quarter at -5422.12.
Average
-10.45
Median
-1.68
Minimum
-79.69
Maximum
-0.05
Discovering the peaks and valleys of H-CYTE, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 624.10%
Maximum Annual PE Ratio = -0.05
Minimum Annual Increase = -96.83%
Minimum Annual PE Ratio = -79.69
Year | PE Ratio | Change |
---|---|---|
2022 | -0.05 | -96.83% |
2021 | -1.68 | 624.10% |
2020 | -0.23 | -44.52% |
2019 | -0.42 | -77.86% |
2018 | -1.89 | 11.70% |
2017 | -1.69 | 55.61% |
2016 | -1.09 | -41.15% |
2015 | -1.85 | -88.45% |
2014 | -15.97 | -79.96% |
The current PE Ratio of H-CYTE, Inc. (HCYT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.65
5-year avg
-0.85
10-year avg
-10.45
H-CYTE, Inc.’s PE Ratio is greater than Algernon Pharmaceuticals Inc. (-0.74), less than Adynxx, Inc. (0), less than Ascletis Pharma Inc. (0), greater than BioCardia, Inc. (-4.99), greater than Genelux Corporation (-0.83), greater than Comera Life Sciences Holdings, Inc. (-3.18), less than Dyadic International, Inc. (-0.00), greater than Cingulate Inc. (-9.00), less than Monopar Therapeutics Inc. (-0.00), greater than Wesana Health Holdings Inc. (-0.54), greater than BioVaxys Technology Corp. (-0.22), greater than GH Research PLC (-3.14), greater than AXIM Biotechnologies, Inc. (-11.64), greater than Aura Biosciences, Inc. (-0.16), greater than Axcella Health Inc. (-5.34), greater than Bavarian Nordic A/S (-3.07), less than Antibe Therapeutics Inc. (14.03), greater than null (-1.06),
Company | PE Ratio | Market cap |
---|---|---|
-0.74 | $1.25M | |
0 | $581.00 | |
0 | $172.62M | |
-4.99 | $10.12K | |
-0.83 | $88.07M | |
-3.18 | $9.22K | |
-0.00 | $57.11M | |
-9.00 | $15.16M | |
-0.00 | $106.08M | |
-0.54 | $68.30K | |
-0.22 | $12.75M | |
-3.14 | $482.30M | |
-11.64 | $694.51K | |
-0.16 | $443.97M | |
-5.34 | $0 | |
-3.07 | $2.21B | |
14.03 | $11.45M | |
-1.06 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like H-CYTE, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like H-CYTE, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is H-CYTE, Inc.'s PE Ratio?
How is the PE Ratio calculated for H-CYTE, Inc. (HCYT)?
What is the highest PE Ratio for H-CYTE, Inc. (HCYT)?
What is the 3-year average PE Ratio for H-CYTE, Inc. (HCYT)?
What is the 5-year average PE Ratio for H-CYTE, Inc. (HCYT)?
How does the current PE Ratio for H-CYTE, Inc. (HCYT) compare to its historical average?